Clover Corporation Limited (ASX:CLV)

Market Cap	92.68M
Revenue (ttm)	72.49M
Net Income (ttm)	4.53M
Shares Out	167.00M
EPS (ttm)	0.03
PE Ratio	20.33
Forward PE	14.02
Dividend	0.02 (2.70%)
Ex-Dividend Date	Apr 9, 2025

Volume	15,272
Average Volume	94,732
Open	0.5550
Previous Close	0.5650
Day's Range	0.5500 - 0.5550
52-Week Range	0.3370 - 0.6000
Beta	0.05
RSI	49.66
Earnings Date	Sep 23, 2025

About Clover Corporation

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm, a microencapsulated powders with the addition of Hi-DHA tuna and/or algal oils. Clover Corporation Limited was incorporated in 1988 and is headquartered in Alton...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1988
• Employees: 60
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CLV

Financial Performance

In 2024, Clover Corporation's revenue was 62.21 million, a decrease of -22.12% compared to the previous year's 79.88 million. Earnings were 1.52 million, a decrease of -75.58%.